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Mutations, induced by free radicals, provide a rich molecular palette that other evolutionary 
forces can select for or against. A recent hypothesis proposed that large numbers of free radicals 
were produced when, millions of years ago, Anthropoidea lost the ability to produce endogenous 
ascorbate, increasing the frequency of mutations and accelerating the evolution of higher 
primates. Recognizing that retroviruses have been active throughout the period of primate 
evolution, we suggest that an endogenous retrovirus or other retroviral-like element may have 
been involved in mutating the gene coding for gulonolactone oxidase (GLO), the terminal step in 
ascorbate synthesis, approximately 45 million years ago. This possibility is supported by the 
presence of Alu elements (a common primate retroelement) adjacent to the site of a missing 
segment of the nonfunctional GLO gene. Although Homo sapiens and other higher primates 
produce other endogenous antioxidants, including superoxide dismutase and uric acid, they do 
not quench the same radicals as ascorbate and cannot fully compensate for a lack of endogenous 
ascorbate. As a consequence, a retrovirus may have played a pivotal role in primate and H. 
sapiens evolution, and the absence of endogenous ascorbate may be continuing to accelerate the 
rate of H. sapiens and primate evolution. 
 
Keywords: Ascorbate | Vitamin C | Free radicals | Evolution | Endogenous retroviruses | 






DNA, deoxyribonucleic acid; GLO, gulonolactone oxidase; RT, reverse transcriptase; SINE, 




Free radicals reactions are well established for their ability to cause random mutations to 
deoxyribonucleic acid (DNA), and the origin of life and the subsequent evolution of species have 
been influenced in part by these mutation-inducing reactions.[1] Unusually high mutation rates 
may accelerate the evolution of species and be advantageous to organisms adapting to new 
environments.[2, 3] A recent hypothesis proposed that large numbers of free radicals were 
created after Anthropoidea lost the ability to produce endogenous ascorbate millions of years 
ago. A high body-burden of free radicals would have increased the frequency of mutations, some 
of which would have been inheritable, and accelerated the evolution of Anthropoidea and the 
emergence of Homo sapiens.[4] 
 
Plant and animal species have a variety of means to minimize free radical damage, such as 
through the upregulation of endogenous antioxidants and antioxidant enzymes. H. sapiens is one 
of the few animal species that does not endogenously produce ascorbate (vitamin C), a powerful 
antioxidant.[5]The gene that codes for the terminal step (gulonolactone oxidase, GLO) in 
ascorbate synthesis was damaged and stopped functioning approximately 45 million years 
ago.[6, 7] 
 
The cause of this genetic damage is unknown, although it has been suggested that it was due to 
radiation exposure.[7] Expanding on an earlier hypothesis, it is also possible that the gene was 
mutated by a virus:[4] specifically, it is proposed that a retrovirus, perhaps an endogenous 
retrovirus, would have been capable of mutating the ascorbate-producing gene. Reverse 
transcriptase (RT) has been a mediator of genetic change for more than three billion years,[8] 
and retroviruses have influenced the evolution of Old World monkeys and hominids.[9] 
 
One family of retroelements that has been widely dispersed in the genomes of all primates 
consists of Alu elements, a type of SINE (short interspersed repetitive element).[10, 11] The 
replication and insertion activity (retroposition) of Alu elements requires the presence of RT in 
the cell, which must be provided by the activity of a (usually endogenous) retrovirus, or other 
RT-encoding retroelement (e.g., a long interspersed repetitive element or a 
retrotransposon). Alu repeats are closely associated with genomic polymorphisms, both 
interspecies (e.g., the α-globin locus in Anthropoids[11]) and intraspecies (e.g., in human 
populations[12]). There is at least tentative evidence that speciation events have been associated 
with the action of transposons or retroelements, including other SINEs (e.g., in zebrafish,[13] 
salmonids,[14] and Drosophila[15]). 
 
Inactivation of the simian GLO gene must have occurred following the divergence from 
prosimians (ascorbate producers), but before the divergence of New World monkeys (GLO 
deficient): thus, between 55 and 35 million years ago. This coincides with the period of the major 
amplification of Alu retroposons throughout simian genomes, 85% of which is believed to have 
occurred early in Anthropoid evolution.[10] Significantly, the sequenced fragment of the 
mutated human GLO gene contains several Alu inserts in intron regions, including two that are 
adjacent to an apparently missing exon (exon XI).[5] Furthermore, Alu inserts and Alu-
Alu recombination events have been identified as a cause of various human genetic 
disorders,[10] including cases of Huntington’s disease, hemophilia (Factor IX gene), 
neurofibromatosis, and adenosine deaminase deficiency. Thus, there is extensive precedent 
for Alu insertion causing a genetic disease, of which loss of GLO leading to ascorbate deficiency 
is perhaps the ultimate example, affecting the entire human species.[4] 
 
This genetic defect in ascorbate production likely allowed large numbers of free radicals to 
remain unquenched through normal metabolic processes. Some of the resulting mutations would, 
because of their random occurrence, have been somatic and others inheritable. Losing the ability 
to manufacture ascorbate, with the subsequent increase of free radicals, would have created a 
palette of mutations that other evolutionary pressures could select for or against.[4] These 
mutations would have aided adaptation to changing environmental conditions. 
 
Other endogenous antioxidants do not appear to fully compensate for the inability to produce 
endogenous ascorbate. For example, while superoxide dismutase (SOD) activity is relatively 
high in species lacking GLO and endogenous ascorbate, SOD cannot fully replace ascorbate, 
because these antioxidants function at different sites and quench different types of radicals.[16] 
Likewise, some higher primates, including H. sapiens, possess a mutated nonfunctional gene for 
urate oxidase, preventing the breakdown of uric acid.[17] Uric acid can function as both a 
prooxidant and antioxidant, but as an antioxidant it does not quench the same radicals as 
ascorbate. In particular, urate does not quench hydroxyl radicals, whereas ascorbate does.[18, 19] 
Because of a lack of endogenous ascorbate, H. sapiens may be continuing to undergo a relatively 
high rate of free radical-induced mutations and evolutionary change. 
 
The role of free radicals in the evolution of species is supported by their role in mutations in 
general. For example, free radical-induced mutations appear to be involved in the etiology of 
some cancers and other diseases.[1, 20] It is conceivable that the incidence of these diseases may 
be a marker of H. sapiens’ evolutionary diversification as a species, with a greater incidence of 
cancer indicative of more mutations, some of which would be inheritable. Conversely, increasing 
ascorbate levels slows the rate of DNA mutations,[21] and ascorbate (and other antioxidants) 
might be of clinical value in the treatment of cancer and other diseases.[22] 
 
This antimutagenic effect of ascorbate would add credence to the role of free radicals and 
ascorbate in influencing the evolution of Anthropoidea and H. sapiens. Furthermore, 
if Alu elements were involved in the primary lesion leading to inactivation of the GLO gene, then 
retroviruses or their cellular ancestors may have played a pivotal role in primate and human 
evolution. 
 
Current dietary recommendations for vitamin C (60 mg/d) are considerably lower than the 
amount generally manufactured by mammals (∼184.2 mg/kg/d).[23] Furthermore, the oxidative 
stress associated with many diseases, may increase ascorbate requirements.[24, 25] Under such 
circumstances, H. sapiens may be continuing to evolve at a faster rate relative to species 




There is evidence suggesting that an endogenous retrovirus or retroviral-like element was 
involved in mutating the GLO gene, which codes for the terminal step in ascorbate synthesis. 
High endogenous production of SOD and urate in H. sapiens and other higher primates would 
not fully compensate for the lack of endogenous ascorbate. 
 
With the loss of endogenous ascorbate production over the past 45 million years, Anthropoidea 
and H. sapiens would be predisposed to a high body burden of free radicals and oxidative stress. 
These free radicals would have increased the frequency of mutations, some of which would have 
been inheritable, accelerating the evolution of Anthropoidea and H. sapiens. High dietary or 
supplemental levels of ascorbate and other antioxidants might protect against retrovirus-induced 
mutations and, in doing so, might slow the evolution of H. sapiens. It would, however, take 
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